Microbiota Bagus Nih
Microbiota Bagus Nih
Microbiota Bagus Nih
Dr Monkez M Yousif
Professor of Internal Medicine
Zagazig University
Member of AGA, Member of EASL
Member of ISC-Hepatitis Working Group
AGENDA
• Overview of Gut Microbiota
• Composition of Gut Microbiota
• Factors and processes that influence community
assembly and composition
• Functions of Gut Microbiota (Symbiosis)
• Techniques of analysis
• Gut Microbiota and Disease
• Fecal Microbiota Transplantation
Diseases of Civilization
Multiple lines of study have shown that the primary cause of this environmental associated
inflammation may be dysfunction of the "gut-brain axis.“ secondary to alteration of gut microbiota.
Quigley, E. M. M. (2017) Gut microbiome as a clinical tool in gastrointestinal disease management: are we there yet?
Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2017.29
The Microbiome: Who’s there?
• Early gut colonization has four phases
– Phase 1: Sterile gut
– Phase 2: Initial acquisition: vagina, feces, hospital
– Phase 3: Breast feeding or bottle-feeding (different)
• Breast fed more bifidobacteria (up to 90% of flora)
• Bottle fed more diverse; more Bacteroides , and
Clostridial species
– Phase 4: Start of solids; move to adult flora (Fermicutes
and bacteriotedes)
• Bifidobacteria remain key flora into adulthood
Ley, Peterson, Gordon. Cell 2006 ;124:837
Ley, et al. PNAS. 2005, 102: 11070
Edwards, et al. Br J Nutr. 2002
Gut Microbiota and Geographic Location
- Once differentiated,
each lineage secretes a
special (set of) cytokine
and perform specific
functions
Protective function (barrier effect)
2 3
5 1
7
The microbiome–gut–brain axis
Modified, with permission, from Elsevier © Collins, S. M. & Bercik P. Gastroenterology 136, 2003–2014 (2009)
Quigley, E. M. M. (2017) Gut microbiome as a clinical tool in gastrointestinal disease management: are we there yet?
Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2017.29
Role of microbiota in
Disease
Dysbiosis and disease
Dysbiosis: Proposed mechanism/s leading to disease
Quigley, E. M. M. (2017) Gut microbiome as a clinical tool in gastrointestinal disease management: are we there yet?
Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2017.29
Dysbiosis and diseases
• Diseases of the GUT
– Malabsorption syndrome
– Malignancies: Colorectal cancer
– Inflammatory Bowl disease (IBD)
– Irritable Bowl syndrome
– Diarrheal diseases
– Clostridium Difficile Infection (CDI)
• Non-mucosal diseases
– Obesity and metabolic syndrome
– Malignancies: liver cancer, breast cancer
– Complications of liver cirrhosis
– Allergic conditions
– Autoimmune disorders (T1DM, arthritis etc)
– Abnormalities of the gut-brain axis- Autism and
other neurological disorders
– Obesity and other metabolic disorders
– Chronic fatigue syndrome
– Periodontal diseases
Malabsorption
syndrome
Malabsorption syndrome
• In health: The bacterial growth is restricted in the upper
small bowel under the influence of acid and motility.
• Factors predisposing to bacterial overgrowth:
Surgical, anatomical, motor (scleroderma & DM), hypochlohydra
(atrophic gastritis, post gastrectomy)
• Consequences of bacterial overgrowth:
– Fat malabsorption due to:
• Bacteria deconjugation of bile acids which allows free bile acids to be
reabsorped decrease luminal bile acid concentration ---limit micelle
formation.
• Patchy mucosal damage by bacteria or toxic effects of FFA
– CHO and protein malabsorption due to mucosal damage or
bacterial metabolism of these nutrients.
– B12 malabsorption: B12 is utilized by the bacteria, in contrast
bacteria produces folic acid.
Gut Microbiota and CDI
Gut Microbiota - CDI
GIT malignancies:
Colorectal cancer
GIT malignancies: Colorectal cancer
Colonic bacteria may initiate cancer through:
1- Production of carcinogens from diets rich in meat and fat
(nitroso compounds).
2- Elevation in damage to DNA of colonic cells by dietary
carcinogens (heterocyclic aromatic amines found in cooked
meat).
3- Abnormalities in repair can lead to neoplastic transformations
4- Microbial metabolism can produce by-products toxic to
epithelium;
5- Disproportionate pro-inflammatory signalling at the GIT
mucosa, leads to increased sloughing and repair of epithelium,
which can ultimately lead to neoplasia and malignancy.
6-Certain microbial species can have direct or indirect (through
host cell activation) cytotoxic effects on cells
• High risk of colon cancer was associated with presence of
– Bacteroides vulgatus and Bacteroides stercoris
• low risk was associated with presence of
– Lactobacillus acidiphilus, Eubacterium aerofaciens.
mucosal inflammation
increased production of pro-inflammatory cytokines by T
helper (TH) cells
TNF, IFNγ, IL-17
TReg transfer can
prevent the induction of
experimental colitis
adapted from Bouma and Strober, Nat rev Immunol., 2003 and Vignali et
al., Nat rev Immunol., 2008
Involvement of the microbiota in regulating the balance
between TH and TReg cell subsets in the gut
TH TReg
Firmicutes
Bacteroidetes
Tang WH, Hazen SL.: The contributory role of gut microbiota in cardiovascular disease.
J Clin Invest. 2014 Oct;124(10):4204-11. doi: 10.1172/JCI72331. Epub 2014 Oct 1.
Neonatal gut microbiota induces lung immunity
against pneumonia
• Streptococcus pneumoniae, Escherichia coli or Candida
albicans were inoculated into newborn mice delivered from
dams that were either untreated or treated 5 days prepartum
with an antibiotic cocktail (ampicillin, gentamicin and
vancomycin).
• Maternal antibiotic exposure reduced the total commensal
bacterial load in the gut of the pups, but also increased the
proliferation of S. pneumonia in the lung.
• Oral inoculation of microbiota from antibiotic-free mice to
pups born from antibiotic-exposed dams restored their
resistance to pneumonia, suggesting that the presence of gut
commensal bacteria is critical for immune responses in the
lung. Gray, J. et al. Intestinal commensal bacteria mediate lung mucosal immunity and promote resistance of
newborn mice to infection. Sci. Transl Med. 9, eaaf9412 (2017).
• Disruption of neonatal gut microbiota can
induce inflammatory responses in the lung.
GUT-LUNG
AXIS
Tamburini, S. & Clemente, J. C. (2017) Neonatal gut microbiota induces lung immunity against pneumonia
Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2017.34
How do we suspect dysbiosis?
• Frequent gas or bloating
• Cramping, urgency, and/or mucus in faeces
• Brain fog, anxiety, or depression
• Food sensitivities
• Chronic bad breath
• Loose stool, diarrhea, constipation, or a combination
• Irritable Bowel Syndrome (IBS)
• History of prolonged antibiotics
• Carbohydrate intolerance, particularly after eating fiber and/or beans
• Fatigue or low energy
• Use of anti-acids for heartburn, reflux, or hiatal hernia?
• Autoimmunity, or an autoimmune condition such as Hashimoto’s
thyroiditis, psoriasis, or multiple sclerosis
• Sinus congestion
Microbiome
shotgun DNA isolation Quantitative PCR
sequencing
Band
resolution
• Non-GI disorders:
– Obesity
– Chronic Fatigue Syndrome
– Autism
The Procedure
• Carefully screened donor stool is mixed with a
saline solution
• The solution is introduced into the GI tract via
a NG tube, fecal enema, oral capsules, or
during a colonoscopy
• The “good” bacteria multiply and help flush
out the C. diff. bacteria
• 92% - 95% success rate
Conclusions
• The human microbiome and the Microbiome
Project: research just beginning…
Monkez M Yousif
67